Search

Corporate M&A pace gathers momentum

Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...

Providing primary eyecare services during a global pandemic: the new normal

It would be fair to say that 2020 hasn’t quite turned out to be the year that anyone predicted. Living with a global pandemic has become our reality and we are having to get used to many aspects of our...

The ocular manifestations of COVID-19: an overview of current literature

Although respiratory symptoms are the most frequent manifestation of COVID-19, multi-organ involvement has been demonstrated, including ocular manifestations. The author investigates how the eye can be affected. The SARS-CoV-2 virus responsible for the COVID-19 pandemic has presented a significant public...

Patient and public participation shapes biomedical research and access priorities in eye health

Patients, clinicians and clinician-scientists play a valuable role in shaping the future of vision research. Limited funding demands targeted research initiatives that ultimately will shape health policy and practice to secure progress in improving patient outcomes in eye health. This...

Building capacity in eye health: A story of partnerships and collaborations

In the evolving landscape of global eye health, partnerships and collaborations have been instrumental in driving capacity building and professional development. The impact of strategic alliances like VISION 2020 LINKS and the Diabetic Retinopathy Network (DR-NET) cannot be overstated, as...

Leveraging networks and collaboration: The Calabar Diabetic Retinopathy Service, from inception to a state-wide service, research and training hub

Diabetic retinopathy (DR), a microvascular complication of diabetes mellitus (DM), is a leading cause of preventable vision loss and blindness in people of working age globally [1]. Diabetic retinopathy is a disease of public health importance in Nigeria as it...